Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
Price Target
Average
61.43%
Revenue Forecast
Estimate
43.47%
EBIT
Estimate
--124.43%
Net Income
Estimate
68.88%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amicus Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for FOLD of $15.7 , with forecasts ranging from
a
low of
$13 to a high of $19 .
FOLD Lowest Price Target
Wall Street Target
13 USD
33.95%
FOLD Average Price Target
Wall Street Target
15.7 USD
61.43%
FOLD Highest Price Target
Wall Street Target
19 USD
95.78%
REVENUE FORECAST
Revenue Forecast Chart FOLD
EBIT FORECAST
EBIT Forecast Chart FOLD
NET INCOME FORECAST
Net Income Chart FOLD